Thomas R. Staab II
2016
In 2016, Thomas R. Staab II earned a total compensation of $719.5K as Senior Vice President and Chief Financial Officer at BioCryst Pharmaceuticals, a 46% decrease compared to previous year.
Compensation breakdown
| Option Awards | $282,798 |
|---|---|
| Salary | $423,417 |
| Other | $13,250 |
| Total | $719,465 |
Staab received $423.4K in salary, accounting for 59% of the total pay in 2016.
Staab also received $282.8K in option awards and $13.3K in other compensation.
Rankings
In 2016, Thomas R. Staab II's compensation ranked 9,754th out of 14,075 executives tracked by ExecPay. In other words, Staab earned more than 30.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,754 out of 14,075 | 31st |
Division Manufacturing | 3,769 out of 5,489 | 31st |
Major group Chemicals And Allied Products | 1,314 out of 1,895 | 31st |
Industry group Drugs | 1,045 out of 1,538 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 183 out of 279 | 34th |
Source: SEC filing on April 12, 2017.
Staab's colleagues
We found four more compensation records of executives who worked with Thomas R. Staab II at BioCryst Pharmaceuticals in 2016.
2016
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2016
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2016
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2016
Yarlagadda Babu
BioCryst Pharmaceuticals